DPP-4 Inhibitors Improve Liver Dysfunction in Type 2 Diabetes Mellitus

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitors might have pleiotropic effects because receptors for incretin exist in various tissues, including liver. We examined whether DPP-4 inhibitors affect liver function in patients with type 2 diabetes. MATERIAL/METHODS: A retrospective review of 459...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanazawa, Ippei, Tanaka, Ken-ichiro, Sugimoto, Toshitsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2014
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4173801/
https://www.ncbi.nlm.nih.gov/pubmed/25228119
http://dx.doi.org/10.12659/MSM.890989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4173801/
https://www.ncbi.nlm.nih.gov/pubmed/25228119
http://dx.doi.org/10.12659/MSM.890989

Ejemplares similares